Article,

The Who, What, and Why of Drug Discovery and Development.

, and .
Trends in pharmacological sciences, 39 (10): 848-852 (October 2018)Recerca clínica; Indústria.
DOI: 10.1016/j.tips.2018.08.002

Abstract

Inquiry into declining pharmaceutical R&D efficiency has focussed on 'what' can be improved, with only brief thought given to 'who' can be improved. Here, we argue that enabling people in the idea-to-product chain to have a more holistic knowledge of the behaviours and incentives of each other can optimise R&D.

Tags

Users

  • @jepcastel

Comments and Reviews